News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Baris Turkbey: Happy to share PI-QUAL version 2
Baris Turkbey/X
May 26, 2024, 06:12

Baris Turkbey: Happy to share PI-QUAL version 2

Baris Turkbey, Head of the Magnetic Resonance Imaging section in MIB, shared a post on LinkedIn:

“Happy to share PI-QUAL version 2
PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI.

Congratulations to our amazing team Jelle Barentsz, Maarten de Rooij, Francesco Giganti, Valeria Panebianco, Anwar Padhani, Veeru Kasi, Caroline Moore, Ivo Schoots, Andrei Purysko, Vibeke Løgager, Rajan T. Gupta, Masoom Haider, Tristan Barrett and all colleagues for this important work.”

Baris Turkbey

Source: Baris Turkbey/X

Andrei Purysko Anwar Padhani Baris Turkbey cancer Caroline Moore Francesco Giganti Ivo Schoots Jelle Barentsz Maarten de Rooij Masoom Haider OncoDaily Oncology Rajan T. Gupta Tristan Barrett Valeria Panebianco Veeru Kasi Vibeke Løgager
Special Coverage
Blog
Jan 3, 2025, 15:57
High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy - JITC
Blog
Jan 3, 2025, 15:31
Gaia Griguolo: TOP1 Mutations are more frequent after treatment with ADCs
Blog
Jan 3, 2025, 15:18
Elvina Almuradova: January is Cervical Cancer Awareness Month
Blog
Jan 3, 2025, 15:10
Unveiling the BGICC 2025 Congress Program
Career
Jan 3, 2025, 13:36
Cancer and Blood Specialists of Arizona Welcome Ronak Rakesh Shah to Its Physician Team
Insight
Jan 3, 2025, 13:31
Mitochondrial DNA's Role in Leukemia Development Explored by St. Jude Scientists
Science
Jan 3, 2025, 13:22
Myeloma Paper of the Day, January 3rd, suggested by Robert Orlowski
Blog
Jan 3, 2025, 13:00
The current treatment process with CAR T cells - Penn Medicine
Science
Jan 3, 2025, 12:51
Targeting Molecular Pathways to Control ICI Toxicities
Insight
Jan 3, 2025, 12:45
Drew Moghanaki: ‘Some pembrolizumab’ is better than ‘No pembrolizumab’ in patients scheduled for preop chemo
Insight
Jan 3, 2025, 12:40
Senthil Kumar: First-Line Therapy in RCC, Expanding Choices in a New Era
Insight
Jan 3, 2025, 12:36
Akhil Santhosh: Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer